<DOC>
	<DOCNO>NCT01416935</DOCNO>
	<brief_summary>The purpose study determine whether anti arrhythmic medication , specifically Amiodarone , require first three month post surgical ablation . Hypothesis : Amiodarone require first three month verify increase rehospitalizations recurrent Atrial Fibrillation , report sinus rhythm surgical follow ( approximately 3 week date surgery ) , 6 week 12 week include patient ' first follow cardiologist approximately 3 month post surgery .</brief_summary>
	<brief_title>Necessity Anti-Arrhythmic Medication After Surgical Ablation Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Amiodarone</mesh_term>
	<mesh_term>Anti-Arrhythmia Agents</mesh_term>
	<criteria>Subject ≥ 18 year age Subject must diagnose Persistent and/or Longstanding Persistent Atrial fibrillation classify HRS Guidelines 8 [ 0 ] Subject must select candidate undergo Cox Maze procedure ablation atrial fibrillation The Cox Maze procedure may do stand alone procedure combine cardiac surgical procedure either via median sternotomy right thoracotomy : Subject Left Ventricular Ejection Fraction ( LVEF ) ≥ 30 % Subject would normally prescribe Amiodarone anti arrhythmic medication post surgical ablation Subject able willing provide write informed consent HIPAA authorization Subject able willing comply study requirement include attend followup visit deem necessary personal physician ( cardiologist ) Subject life expectancy least one year Subject undergone previous attempt surgical Maze procedure AF operation , include surgical catheter ablation Subject accessory pathway disorder ( e.g . WolffParkinsonWhite syndrome ) Subject Class IV NYHA Subject document MI within 6 week prior study enrollment Subject need emergent cardiac surgery ( i.e . cardiogenic shock ) Subject know carotid artery stenosis great 80 % Subject current diagnosis active systemic infection Subject pregnant , plan become pregnant within 1214 month , lactate Subject require preoperative intraaortic balloon pump intravenous inotropes Subject renal failure require dialysis Subject diagnose hepatic failure Subject antiarrhythmic drug therapy treatment ventricular arrhythmia Subject know connective tissue disorder Subject incarcerate Subject previous current therapy could compromise tissue integrity include thoracic radiation , chemotherapy , longterm oral inject steroid Subject intravenous drug and/or alcohol abuser Subject participate concomitant research study investigational product ( e.g . Appendage closure device , atrial septal defect patch )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Anti-Arrhythmic Medication</keyword>
</DOC>